CardioCytogen
Also known as: CardioCytogen
CardioCytogen is a proprietary short-peptide bioregulator marketed for cardiovascular and heart-tissue support. It is sold as a research chemical with limited published characterization.
Last updated
Mechanism of Action
CardioCytogen is positioned within the Khavinson peptide bioregulator framework, in which tissue-specific ultrashort peptides are proposed to enter cells, interact with DNA regulatory regions, and normalize gene expression in their target tissue. For a cardiac-directed bioregulator, the marketed rationale is restoration of cardiomyocyte protein synthesis, support of myocardial function, and protection against age-related and stress-induced cardiac dysfunction. Because compound-specific peer-reviewed data are limited, this mechanism is inferred from the broader cardiogen/bioregulator class rather than dedicated trials.
- Half-life
- Not established; short bioregulator peptides are generally cleared within hours
- Administration Routes
- subcutaneous, oral
- Research Status
- Research Chemical
Reported Benefits
- Marketed for cardiovascular and myocardial support
- Proposed tissue-specific regenerative effects on heart cells
- Positioned for healthy cardiac aging
- Framed as supporting recovery from cardiac stress
- Proposed antioxidant protection of cardiac tissue
Potential Side Effects
- Poorly characterized safety profile
- Possible injection-site irritation
- Unknown cardiovascular effects in humans
- Unknown long-term effects
Common Dosing
For research use only and not medical advice: peptide bioregulators are typically referenced at low microgram-to-low-milligram amounts in short cyclical courses, subcutaneous or oral. No validated dosing exists for CardioCytogen specifically.
The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.
Contraindications
- Active cardiac disease without medical supervision
- Pregnancy or breastfeeding
- Known peptide hypersensitivity
Cardiogen
Cardiogen is a short synthetic peptide (Ala-Glu-Asp-Arg) studied as a cardiovascular bioregulator intended to support heart and vascular tissue. It belongs to the Khavinson family of short peptide bioregulators.
Actogenix
Actogenix is a proprietary peptide-bioregulator-style product marketed for vitality, energy, and healthy-aging support. It is sold as a research chemical with limited published data.
Epitalon
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the pineal peptide epithalamin, studied for telomerase activation, circadian regulation, and longevity in animal and limited human research.
No notable studies catalogued for CardioCytogen yet.